Cargando…

Durability of Complete Response to Intralesional Interleukin-2 for In-Transit Melanoma

BACKGROUND: Intralesional injection of interleukin-2 (IL-2) for in-transit melanoma (ITM) is associated with a high rate of complete response. However, there is a paucity of data on treatment durability and long-term outcomes. OBJECTIVES: To provide long-term data on patients with a complete respons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khoury, Sami, Knapp, Gregory C., Fyfe, Allison, Monzon, Jose, Temple-Oberle, Claire, McKinnon, Gregory J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311908/ https://www.ncbi.nlm.nih.gov/pubmed/33529083 http://dx.doi.org/10.1177/1203475420988862

Ejemplares similares

Higher Rate of Lymphedema with Inguinal versus Axillary Complete Lymph Node Dissection for Melanoma: A Potential Target for Immediate Lymphatic Reconstruction?
por: Deban, Melina, et al.
Publicado: (2022)

Not Waiting to Progress; How the COVID-19 Pandemic Nudged Neoadjuvant Therapy for Stage III Locally Advanced Melanoma Patients
por: Kinaschuk, Katie, et al.
Publicado: (2023)

Mitigating Breast-Cancer-Related Lymphedema—A Calgary Program for Immediate Lymphatic Reconstruction (ILR)
por: Deban, Melina, et al.
Publicado: (2023)

Intraoperative Near-infrared Spectroscopy Correlates with Skin Flap Necrosis: A Prospective Cohort Study
por: Hill, William F., et al.
Publicado: (2020)

Treatment of melanoma in-transit metastases with combination intralesional interleukin-2, topical imiquimod, and tretinoin 0.1% cream
por: Leventhal, Jonathan S., et al.
Publicado: (2016)

Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases
por: Radny, P, et al.
Publicado: (2003)

Canadian Melanoma Conference Recommendations on High-Risk Melanoma Surveillance: A Report from the 14th Annual Canadian Melanoma Conference; Banff, Alberta; 20–22 February 2020
por: Lee, Christina W., et al.
Publicado: (2021)

Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
por: Pourmaleki, Maryam, et al.
Publicado: (2022)

Intralesional therapy for advanced melanoma: promise and limitation
por: Agarwala, Sanjiv S.
Publicado: (2015)

Current status of intralesional agents in treatment of malignant melanoma
por: Zawit, Misam, et al.
Publicado: (2021)

Topical and Intralesional Immunotherapy for Melanoma In Situ: A Review
por: Martínez-Fernández, Sandra, et al.
Publicado: (2023)

Kikuchi-Fujimoto lymphadenitis imitating metastatic melanoma on positron emission tomography: a case report
por: Urbanellis, Peter, et al.
Publicado: (2015)

Resolution of Metastatic Subungal Eccrine Porocarcinoma Treated with Intralesional Interleukin-2
por: Drohan, Ashley, et al.
Publicado: (2020)

Insights into the Molecular Mechanisms Behind Intralesional Immunotherapies for Advanced Melanoma
por: Vidovic, Dejan, et al.
Publicado: (2020)

Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma
por: Ferrucci, Pier Francesco, et al.
Publicado: (2021)

Additive Intralesional Interleukin-2 Improves Progression-Free Survival in a Distinct Subgroup of Melanoma Patients with Prior Progression under Immunotherapy
por: Rafei-Shamsabadi, David, et al.
Publicado: (2022)

Intralesional PV‐10 for the treatment of in‐transit melanoma metastases—Results of a prospective, non‐randomized, single center study
por: Read, Tavis A., et al.
Publicado: (2018)

Complete Resolution of Cystic Hygroma with Single Session of Intralesional Bleomycin
por: Sharif, Muhammad, et al.
Publicado: (2012)

Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma
por: Thompson, John F., et al.
Publicado: (2014)

Durable clinical remission of a skull metastasis under intralesional Viscum album extract therapy: Case report
por: Werthmann, Paul Georg, et al.
Publicado: (2018)

Treatment of In-Transit Melanoma With Intralesional Bacillus Calmette-Guérin (BCG) and Topical Imiquimod 5% Cream: A Report of 3 Cases
por: Kibbi, Nour, et al.
Publicado: (2015)

YIMBY—Yes, In My BackYard!—The successful transition to a local online ecology field course
por: McKinnon, Laura
Publicado: (2020)

Intralesional Rose Bengal in melanoma elicits tumor immunity via HMGB1
por: Liu, Hao, et al.
Publicado: (2015)

Advances in Intralesional Therapy for Locoregionally Advanced and Metastatic Melanoma: Five Years of Progress
por: DePalo, Danielle K., et al.
Publicado: (2023)

Results of a phase II, open‐label, non‐comparative study of intralesional PV‐10 followed by radiotherapy for the treatment of in‐transit or metastatic melanoma
por: Foote, Matthew, et al.
Publicado: (2017)

Is multiple session of intralesional bleomycin mandatory for complete resolution of macrocystic lymphatic malformation?
por: Upadhyaya, Vijai Datta, et al.
Publicado: (2018)

Complete clearance of periungual warts in an immunocompromised patient using diluted intralesional bleomycin
por: Altalhab, Saad
Publicado: (2022)

Intralesional Candida albicans antigen versus intralesional zinc sulfate in treatment of cutaneous warts
por: Youssef, Eman M. Kamal, et al.
Publicado: (2022)

Intralesional Steroids for Alopecia Areata
por: Kumaresan, M
Publicado: (2010)

Topical and intralesional therapies for in-transitmelanoma
por: Henderson, Michael A
Publicado: (2019)

Efficacy of intralesional injection with PV-10 in combination with co-inhibitory blockade in a murine model of melanoma
por: Pilon-Thomas, Shari, et al.
Publicado: (2014)

Scalp In-Transit Metastatic Melanoma Treated with Interleukin-2 and Pulsed Dye Laser
por: Wang, Michael Z., et al.
Publicado: (2013)

Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program
por: Payne, Roxanne, et al.
Publicado: (2014)

Comparison of Intralesional Meglumine Antimonite along with oral Itraconazole to Intralesional Meglumine Antimonite in the treatment of Cutaneous Leishmaniasis
por: Bashir, Uzma, et al.
Publicado: (2019)

Cidofovir Intralesional Injection for Recalcitrant Common Warts: A Comparison with Sodium Tetradecyl Sulfate Intralesional Injection
por: Oh, Byung Ho
Publicado: (2020)

Robust tumor immunity to melanoma mediated by interleukin 9
por: Purwar, Rahul, et al.
Publicado: (2012)

Inflammatory melanoma in transit metastases with complete response to talimogene laherparepvec
por: Blackmon, Jonathan T., et al.
Publicado: (2017)

Case Report: Durable complete pathologic response and organ preservation following ipilimumab and nivolumab for locally advanced primary vaginal mucosal melanoma
por: Tarhini, Ahmad A., et al.
Publicado: (2022)

Interleukins in the treatment of melanoma
por: Xu, Xinyuan, et al.
Publicado: (2022)

Lymphangioma: Is intralesional bleomycin sclerotherapy effective?
por: Rozman, Z, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hghvti05l3qa6ok22vo7at46hl